Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Study finds link between COVID-19 infection and neurological complications

October 27, 2021 Research and Development

A study conducted by Nature Medicine has revealed an increased risk of Guillain-Barre Syndrome (GBS) and Bell’s palsy following a …
News

FDA and EMA approve Novartis’ treatment for follicular lymphoma patients

October 27, 2021 Research and Development

The FDA and EMA have accepted Novartis’ Supplemental Biologics License Application (sBLA) and Type II Variation for KymriahⓇ in patients …
News

IXICO partner with Microsoft to enhance AI platform

October 20, 2021 Research and Development

IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI …
News

Synairgen COVID-19 treatment moves to Phase III trials

October 20, 2021 Research and Development

Synairgen PLC have said that its anti-viral treatment for severe lung infections is advancing to the final stage of clinical …
News

Pharma Innovation Award given to Stevanato Group for AI-ready vision Robot Unit

October 20, 2021 Research and Development

Stevanato Group, a global provider of processes and services for the Pharmaceutical and Healthcare industry, has been announced as a …
News
mufid-majnun-oi20ehignd4-unsplash

UK COVID deaths highest since March – Doctors call for urgent return of restrictions

October 20, 2021 Research and Development

Medical professionals in the NHS have urgently pleaded the UK government to reimpose COVID restrictions as UK COVID deaths reach …
News

England care staff shortage puts thousands at risk

October 20, 2021 Research and Development

Managers of community care services for over 15,000 people in England say that staff shortages have led to them turning …
News

Verona Pharma to present Phase II data with pMDI for COPD patients

October 13, 2021 Research and Development

Clinical-stage biopharmaceutical company, Verona Pharma plc (Verona), is due to present Phase II data demonstrating the positive effect of a …
News

Empagliflozin (Jardiance®) receives SMC approval for treatment of heart failure

October 13, 2021 Research and Development

The Scottish Medicines Consortium (SMC) has announced that empagliflozin (Jardiance®) has been accepted for use by NHS Scotland, for the …
News
moderna_norwood_plant

Gavi to purchase 176.5 million doses of Moderna COVID-19 vaccine for low income countries

October 13, 2021 Research and Development

COVAX has purchased more than 210 million doses of their vaccine for delivery to low income countries. This supply agreement …
News
pfizer

Pfizer enlists entire town in Brazil for COVID study

October 7, 2021 Research and Development

An entire town in Brazil has been enrolled by Pfizer to study the transmission of the coronavirus within a vaccinated …
News

WHO rolls out GSK’s malaria vaccine in Africa

October 7, 2021 Medical Communications, Research and Development

The WHO has given the go-ahead for the mass roll out of a malaria vaccine for children, in a historic …
News

Janssen’s bowel disease drug shown to be safe for use in older patients

October 6, 2021 Research and Development

The Janssen Pharmaceutical Companies of J&J have announced that STELARA® (ustekinumab) has a high safety profile in older patients across …
News

UroGen Pharma shows positive results for bladder cancer patients

October 6, 2021 Research and Development

UroGen Pharma Ltd has published results from the Phase IIb OPTIMA II trial, a single-arm trial studying UGN-102 (mitomycin) as …
News

Third dose of COVID-19 vaccine approved for immunocompromised over 12

October 6, 2021 Research and Development

The EMA have authorised the third dose of the Moderna COVID-19 vaccine (Spikevax), to be administered on immunocompromised individuals aged …
News
The Gateway to Local Adoption Series

Latest content

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026